54. Chipps, B.E. Update on the 2007 National Asthma Education and Prevention Program: Guidelines for the Treatment of Asthma in Children. Supplement to Consultant for Pediatricians. 2008;7:1. View

53. Chipps, B.E. How Pediatric and Adult Asthma Differ, with Implications for Treatment. Respiratory Digest. 2008;9: 3-13. View

52. Lee, J., Haselkorn, T., Borish, L., Rasouliyan, L.H., Chipps, B.E., Wenzel, S. Risk Factors Associated with Persistent Airflow Limitation in Severe to Difficult-to-Treat Asthma. CHEST. 2007;132:1882-1889. View

51. Chipps, B.E., Sezefler, S.J., Simons, E.R., Haselkorn, T., Mink, D.R., Deniz, Y., Lee, J.H., TENOR Study Group. Demographic and Clinical Characteristics of Children and Adolescents with Severe or Difficult-to-Treat Asthma. J Allergy Clin Immunol. 2007;119:1156-63. View

50. Sullivan, S.D., Rasouiyan, L., Russo, P.A., Kamath, T., Chipps, B.E., for the Tenor Study Group. Extent, Patterns, and Burden of Uncontrolled Disease in Severe or Difficult-to-Treat Asthma. Allergy. 2007;62:126-133. View

49. Chipps, B.E., Harder J. Targeted Interventions for Difficult-to-Treat Asthma. Expert Opinion. 2007;11:11-20. View

48. Chipps, B.E., Spahn, J.D. What Are the Determinates of Asthma Control? J Asthma. 2006;43:567-572. View

47. Chipps, B.E., Buhl, R., Beeh, K.M., Fox, H., Thomas, K., Reisner, C. Improvement in Quality of Life with Omalizumab in Patients with Sever Allergic Asthma. Current Medical Research and Opinion. 2006;22:2201-2208. View